Health CareHealth Care Equipment & Services
  • Price (USD)91.53
  • Today's Change0.47 / 0.52%
  • Shares traded1.06m
  • 1 Year change10.05%
  • Beta0.5903
Data delayed at least 15 minutes, as of Oct 16 2017 21:02 BST.
More ▼

Key statistics

On Monday, Quest Diagnostics Inc (DGX:NYQ) closed at 91.53, 15.69% above the 52 week low of 79.12 set on Oct 28, 2016.
52-week range
79.12Oct 28 2016112.97Jul 03 2017
Markit short selling activity
Previous close91.06
Average volume1.31m
Shares outstanding136.41m
Free float135.82m
P/E (TTM)18.30
Market cap12.49bn USD
EPS (TTM)5.00
Annual div (ADY)1.80
Annual div yield (ADY)1.98%
Div ex-dateOct 02 2017
Div pay-dateOct 18 2017
Data delayed at least 15 minutes, as of Oct 16 2017 21:02 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.